Literature DB >> 26718478

Treatment of Hepatitis C Infection in Renal Transplant Recipients: The Long Wait Is Over.

V Saxena1, N A Terrault1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26718478      PMCID： PMC5899894          DOI： 10.1111/ajt.13697

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  5 in total

Review 1.  The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.

Authors:  Norah A Terrault; Deborah B Adey
Journal:  Clin J Am Soc Nephrol       Date:  2007-03-14       Impact factor: 8.237

2.  Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents.

Authors:  D Sawinski; N Kaur; A Ajeti; J Trofe-Clark; M Lim; M Bleicher; S Goral; K A Forde; R D Bloom
Journal:  Am J Transplant       Date:  2016-02-05       Impact factor: 8.086

Review 3.  Hepatitis C virus and nonliver solid organ transplantation.

Authors:  Marco Carbone; David Mutimer; James Neuberger
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

4.  Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation.

Authors:  N Kamar; O Marion; L Rostaing; O Cointault; D Ribes; L Lavayssière; L Esposito; A Del Bello; S Métivier; K Barange; J Izopet; L Alric
Journal:  Am J Transplant       Date:  2015-11-20       Impact factor: 8.086

Review 5.  Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant Patients.

Authors:  Varun Saxena; Norah Terrault
Journal:  Clin Liver Dis       Date:  2015-07-26       Impact factor: 6.126
  5 in total
  4 in total

1.  Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients.

Authors:  Kohei Unagami; Hideki Ishida; Masayoshi Okumi; Toshihito Hirai; Daisuke Toki; Kazuya Omoto; Tomokazu Shimizu; Masashi Inui; Kosaku Nitta; Kazunari Tanabe
Journal:  Transplant Direct       Date:  2016-08-26

Review 2.  Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients.

Authors:  Armando Calogero; Evangelista Sagnelli; Massimiliano Creta; Silvia Angeletti; Gaia Peluso; Paola Incollingo; Maria Candida; Gianluca Minieri; Nicola Carlomagno; Concetta Anna Dodaro; Massimo Ciccozzi; Caterina Sagnelli
Journal:  Biomed Res Int       Date:  2019-04-07       Impact factor: 3.411

3.  Direct-acting Antiviral Agents in Hepatitis C Virus-infected Renal Allograft Recipients: Treatment and Outcome Experience from Single Center.

Authors:  N Prasad; M R Patel; A Pandey; A Jaiswal; D Bhadauria; A Kaul; R K Sharma; S Mohindra; G Pandey; A Goel; A Gupta
Journal:  Indian J Nephrol       Date:  2018 May-Jun

4.  Successful Kidney Transplantation in a Recipient Coinfected with Hepatitis C Genotype 2 and HIV from a Donor Infected with Hepatitis C Genotype 1 in the Direct-Acting Antiviral Era.

Authors:  Dimitrios Farmakiotis; Zoe Weiss; Amy L Brotherton; Paul Morrissey; Reginald Gohh; Kendra Vieira; Lynn E Taylor; Joseph M Garland
Journal:  Case Reports Hepatol       Date:  2020-01-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.